These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 12599571

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Role of estrogens in the secondary hormonal manipulation of hormone refractory prostate cancer.
    Siddiqui K, Abbas F, Biyabani SR, Ather MH, Talati J.
    J Pak Med Assoc; 2004 Sep; 54(9):445-7. PubMed ID: 15518364
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Use of intravenous stilbestrol diphosphate in patients with prostatic carcinoma refractory to conventional hormonal manipulation.
    Ferro MA.
    Urol Clin North Am; 1991 Feb; 18(1):139-43. PubMed ID: 1992567
    [Abstract] [Full Text] [Related]

  • 8. [High-dose intravenous estrogen therapy].
    Moriguchi H, Yoshida K, Kitahara S.
    Nihon Rinsho; 2000 Jul; 58 Suppl():330-4. PubMed ID: 11022743
    [No Abstract] [Full Text] [Related]

  • 9. [Inhibition of prostate cancer growth in nude mice by hormone and chemotherapy].
    Fujita K, Satake H, Fujioka A, Uchida J, Takeda S, Unemi N.
    Gan To Kagaku Ryoho; 1996 Sep; 23(10):1335-8. PubMed ID: 8831749
    [Abstract] [Full Text] [Related]

  • 10. How to manage hot flashes in prostate cancer?
    Baum N.
    Postgrad Med; 2003 May; 113(5):4. PubMed ID: 12764891
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [ST52 treatment of cancer of the prostate during the hormonal resistance phase].
    Grise P, Mnif A, Navarra S, Foulatier O, Barret E, Sibert L, Pfister C.
    Ann Urol (Paris); 1998 May; 32(1):39-44. PubMed ID: 9559075
    [Abstract] [Full Text] [Related]

  • 14. The nonsteroidal effects of diethylstilbestrol: the rationale for androgen deprivation therapy without estrogen deprivation in the treatment of prostate cancer.
    Scherr DS, Pitts WR.
    J Urol; 2003 Nov; 170(5):1703-8. PubMed ID: 14532759
    [Abstract] [Full Text] [Related]

  • 15. [Step up therapy].
    Shiono A, Kurokawa K, Ito K, Yamanaka H.
    Nihon Rinsho; 2000 Jul; 58 Suppl():292-4. PubMed ID: 11022732
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Cytotoxicity and metabolism of E-DES-diphosphate.
    Oelschläger H, Rothley D, Dunzendorfer U.
    Prog Clin Biol Res; 1989 Jul; 303():187-95. PubMed ID: 2780647
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.